Literature DB >> 25142245

Molecular characterization of circulating tumor cells: Holy Grail for personalized cancer treatment?

Evi S Lianidou1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25142245     DOI： 10.1373/clinchem.2014.230144

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

Review 1.  Circulating tumor cell isolation, culture, and downstream molecular analysis.

Authors:  Sandhya Sharma; Rachel Zhuang; Marisa Long; Mirjana Pavlovic; Yunqing Kang; Azhar Ilyas; Waseem Asghar
Journal:  Biotechnol Adv       Date:  2018-03-17       Impact factor: 14.227

2.  Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery.

Authors:  Jérôme Alexandre Denis; Alexia Patroni; Erell Guillerm; Dominique Pépin; Naoual Benali-Furet; Janine Wechsler; Gilles Manceau; Maguy Bernard; Florence Coulet; Annette K Larsen; Mehdi Karoui; Jean-Marc Lacorte
Journal:  Mol Oncol       Date:  2016-06-07       Impact factor: 6.603

3.  Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer.

Authors:  Maria Chimonidou; Areti Strati; Nikos Malamos; Sophia Kouneli; Vassilis Georgoulias; Evi Lianidou
Journal:  Oncotarget       Date:  2017-06-27

4.  Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple-negative breast cancer patients.

Authors:  Ann-Kathrin Bittner; Corinna Keup; Oliver Hoffmann; Siegfried Hauch; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  J Cell Mol Med       Date:  2020-06-18       Impact factor: 5.310

5.  CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosis.

Authors:  Galatea Kallergi; Oliver Hoffmann; Ann-Kathrin Bittner; Lina Papadimitriou; Spyridoula D Katsarou; Nefeli Zacharopoulou; Michalis Zervakis; Stelios Sfakianakis; Christos Stournaras; Vassilis Georgoulias; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  Ther Adv Med Oncol       Date:  2020-04-28       Impact factor: 8.168

Review 6.  Current Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous System.

Authors:  Lukasz A Adamczyk; Hannah Williams; Aleksandra Frankow; Hayley Patricia Ellis; Harry R Haynes; Claire Perks; Jeff M P Holly; Kathreena M Kurian
Journal:  Front Neurol       Date:  2015-08-10       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.